Form 4 holding
Chief Accounting Officer
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 6,500
- Estimated value
- $54,925
- Report date
- 02 Jan 2026
- Price
- $8.45
- Ownership
- Direct
June Ann Seymour - Chief Accounting Officer at Cartesian Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Accounting Officer
- Issuer symbol
- RNAC on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
No buys or sells have been reported by June Ann Seymour since 03 Jun 2025
Reported holdings for June Ann Seymour in Cartesian Therapeutics, Inc.
Form 4 holding
Chief Accounting Officer
Cartesian Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 19,000
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for June Ann Seymour in Cartesian Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.